Skip to content

Home
News Categories
About Lymphoma
Treatments
- Approved Treatments
- Experimental Treatments
Columns
Information About COVID-19

Search for:

RP-323

March 20, 2018March 20, 2018

Rich’s RP-323 Shows Activity Against Hodgkin’s Lymphoma in Phase 1 Trial

News

Experimental therapy RP-323 has shown anticancer activity against Hodgkin’s lymphoma in a Phase 1 trial. Its developer, Rich Pharmaceuticals, is now planning to evaluate the therapy in human clinical trials for the disease. ... Read more

Search for:

Recent Posts

A Farewell Note to My Beloved Readers

February 26, 2021
A Light-giver Shares a Lesson in Emotional Honesty

February 15, 2021
Embarking on a New Chapter While Cherishing the Value of Community

February 1, 2021

Featured Posts

FDA Grants Orphan Drug Status to Umbralisib for Follicular Lymphoma

March 19, 2020

The Paradox of Healing

March 9, 2020

Visit Lymphoma News Today's profile on Pinterest.

Bionews, Inc.

3 W Garden St

Suite 700
Pensacola, FL 32502
Email: info@Bionews.com
Phone: +1-800-936-1363

About Us
Our Team
Our Guiding Ethics
Contact Us
Terms of Service
Privacy Policy

Disclaimer:

Lymphoma News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.

Copyright © 2013-2025 Copyright 2015 © All rights reserved